Can you explain the current market issues of the pharmaceutical industry? We believe that all parties involved in, ultimately want the same outcome – fairly-priced, reliable quality medicines with equitable availability. If the old pricing system is bought back, will it be a disadvantage to the people? How should the pharmaceutical industry focus be changed along with the emerging health issues (eg. However, this is incrementally complicated in the pharmaceutical industry where there are 3,500 brands available.
Source: Sunday Observer October 13, 2018 19:14 UTC